Last reviewed · How we verify

Qishenyiqi dripping pills 1 bag, three times a day

Qilu Hospital of Shandong University · FDA-approved active Small molecule Quality 2/100

Qishenyiqi dripping pills 1 bag, three times a day is a Small molecule drug developed by Qilu Hospital of Shandong University. It is currently FDA-approved.

At a glance

Generic nameQishenyiqi dripping pills 1 bag, three times a day
SponsorQilu Hospital of Shandong University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Qishenyiqi dripping pills 1 bag, three times a day

What is Qishenyiqi dripping pills 1 bag, three times a day?

Qishenyiqi dripping pills 1 bag, three times a day is a Small molecule drug developed by Qilu Hospital of Shandong University.

Who makes Qishenyiqi dripping pills 1 bag, three times a day?

Qishenyiqi dripping pills 1 bag, three times a day is developed and marketed by Qilu Hospital of Shandong University (see full Qilu Hospital of Shandong University pipeline at /company/qilu-hospital-of-shandong-university).

What development phase is Qishenyiqi dripping pills 1 bag, three times a day in?

Qishenyiqi dripping pills 1 bag, three times a day is FDA-approved (marketed).

Related